Immediate Impact

4 by Nobel laureates 8 from Science/Nature 82 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
2022 Standout
5 intermediate papers

Works of É. Luporsi being referenced

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
2014
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
2005

Author Peers

Author Last Decade Papers Cites
É. Luporsi 517 221 228 283 62 952
C. Parsons 376 219 156 338 40 889
J.J. Mazeron 555 238 165 497 32 1.1k
Li‐Min Sun 246 177 110 274 45 825
George Plataniotis 341 238 163 231 40 1.0k
Jiřı́ Petera 332 362 129 276 103 925
Kaoru Hirabayashi 455 245 88 286 55 837
Michitaka Yamakawa 411 457 155 322 47 1.0k
C. Durdux 297 318 136 243 91 964
José Luis Guinot 295 175 550 323 42 1.0k
Herman Nussbaum 448 202 129 597 54 1.0k

All Works

Loading papers...

Rankless by CCL
2026